Diamond Healthcare to Offer AssureRx's PGx Test to Guide Antipsychotic Therapy
September 29, 2010
Diamond Healthcare to Offer AssureRx's PGx Test to Guide Antipsychotic Therapy
Diamond Healthcare will initially provide AssureRx Health's GeneSightRx psychiatric pharmacogenetic test in 10 of its behavioral health units, but plans to expand adoption of PGx testing within its 30-state network.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- AssureRx Updates PGx Test for Assessing Best Responders to Psychotropic Drugs
January 18, 2012 / Pharmacogenomics Reporter - Medco to Evaluate Clinical Utility of AssureRx's PGx Test in Guiding Psychiatric Treatment
May 18, 2011 / Pharmacogenomics Reporter - AssureRx Raises $11M in Series B Round
March 25, 2011 / GenomeWeb Daily News - AssureRx Updates GeneSightRx Panel with New Gene: CYP1A2
March 10, 2010 / Pharmacogenomics Reporter - New Releases
October 27, 2009 / Pharmacogenomics Reporter